Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

NTSAD In The News

NTSAD In The News

Huffington Post - "Two Research Grants Approved to Help Late Onset Tay Sachs"Published: June 2015

Boston Business Journal - 'This disease takes away everything': One family's story of Tay-Sachs
Published: February 27, 2015. The first clue that something might be wrong with Cameron was, oddly enough, a diagnosis of Tay-Sachs disease in her cousin.

Boston Business Journal - With the help of patient groups, biotechs hone in on rare diseases
Published: February 26, 2015. Shire Pharmaceuticals made its name developing drugs for osteoporosis, Alzheimer's disease and attention deficit hyperactivity disorder, but its future lies firmly in treatments for rare diseases.

Back Issues

Visit our library of eNews for copies of past newsletters, research updates, topics of the week and more